Abbott turned a page for its US powder infant formula business in its latest quarter and forecast more progress ahead after meeting its federal Women, Infants, and Children program order backlog and starting distribution to retailers.
“The inventory levels on the WIC contracts are very good as we entered into Q4. We then started focus on...